期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

巨噬细胞移动抑制因子基因多态性与冠心病关联性研究新进展 被引量：8

MIF Gene Polymorphisms Associated with Coronary Heart Disease
下载PDF
导出
摘要 冠心病是一种环境和遗传因素相互作用的疾病。从基因方面对冠心病的发生进行阐明,将会使冠心病的预防、诊治进入一个新的领域。巨噬细胞移动抑制因子目前被认为是冠心病发生发展中的关键因素。因此,现从巨噬细胞抑制因子的基因多态性与冠心病的相关性进行综述。 Coronary heart disease （CHD） is a disease, which is related to environmental and genetic factors. To understand CHD in gene, will make the prevention, diagnosis and treatment of CHD to get into a new era. Maerophage migration inhibitory factor （MIF） is con sidered to be a key factor in the development of CHD. Therefore, this paper summarizes the association of the polymorphism of the MIF gene and CHD.
作者 徐锐 杨毅宁
机构地区 新疆医科大学第一附属医院心脏中心
出处 《心血管病学进展》 CAS 2014年第1期71-74,共4页 Advances in Cardiovascular Diseases
基金 新疆维吾尔自治区自然科学基金(2010211A44)
关键词 巨噬细胞移动抑制因子 基因多态性 冠心病 macrophage migration inhibition faetor gene polymorphism coronary heart disease
分类号 R541.4 [医药卫生—心血管疾病]
  • 相关文献

参考文献27

  • 1单志新,符永恒,余细勇,邓春玉,谭虹虹,林秋雄,于汇民,林曙光.巨噬细胞移动抑制因子-173G/C多态性与冠心病的相关性研究[J].中华医学遗传学杂志,2006,23(5):548-550. 被引量：19
  • 2Bloom BR,Bennett B. Mechanism of a reaction in vitro associated with delayedtype hypersensitivity[J].{H}SCIENCE,1996,(1):80-82.
  • 3Grieb G,Simons D,Eckert L. Levels of macrophage migration inhibitory factor and glucocorticoids in chronic wound patients and their potential interactions with impaired wound endothelial progenitor cell migration[J].{H}WOUND REPAIR AND REGENERATION,2012,(5):707-714.
  • 4Shan ZX,Lin QX,Yang M. Transcription factor Ap-1 mediates proangiogenic MIF expression in human endothelial cells exposed to angiotensin Ⅱ[J].{H}CYTOKINE,2011,(1):35-41.
  • 5Roger T,Ding X,Chanson AL. Regulation of constitutive and microbial pathogen-induced human macrophage migration inhibitory factor (MIF) gene expression[J].{H}European Journal of Immunology,2007,(12):3509-3521.
  • 6Broekhuizen LN,van Wijk DF,Vink H. Reduction of monocyte chemoattractant protein 1 and macmphage migration inhibitory factor by a polyphenolrich extract in subjects with clustered cardiometabolic risk factors[J].{H}British Journal of Nutrition,2011,(9):1416-1422.
  • 7Asare Y,Schmitt M,Bemhagen J. The vascular biology of macmphage migration inhibitory factor (MIF).Expression and effects in inflammation,atherogenesis and angiogenesis[J].{H}Thrombosis and Haemostasis,2013,(3):391-398.
  • 8Flex A,Gaetani E,Angelini F. Pro-inflammatory genetic profiles in subjects with peripheral arterial occlusive disease and critical limb ischemia[J].{H}Internal Medicine,2007,(1):124-130.
  • 9Donn R,Alourfi Z,de Benedetti F. Mutation screening of the macrophage migration inhibitory factor gene:positive association of a functional polymorphism of macrophage migration inhibitory factor with juvenile idiopathic arthritis[J].{H}ARTHRITIS AND RHEUMATISM,2002,(9):2402-2409.
  • 10Lugrin J,Ding XC,le Roy D. Histone deacetylase inhibitors repress macrophage migration inhibitory factor (MIF)expression by targeting MIF gene transcription through a local chromatin deacetylation[J].{H}Biochimica et Biophysica Acta,2009,(11):1749-1758.

二级参考文献32

  • 1Hsiang CY, Wu SL, Chen JC, et al. Acetaldehyde induces matrix metalloproteinase-9 gene expression via nuclear factor-kappaB and activator protein 1 signaling pathways in human hepatocellular carcinoma cells: association with the invasive potential. Toxicol Lett, 2007,171:78-86.
  • 2Onodera S, Nishihira J, Iwabuchi K, et al. Macrophage migration inhibitory factor up-regulates matrix metalloproteinase-9 and -13 in rat osteoblasts. Relevance to intracellular signaling pathways. J Biol Chem, 2002, 277:7865-7874.
  • 3Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol, 1983, 51:606.
  • 4ACC/AHA Task Force. Guidelines for percutaneous transluminal coronary angioplasty. A report of the American College of Cardiology/American Heart Association Task Force on Assessment of Diagnostic and Therapeutic Cardiovascular Procedures ( Subcommittee on Percutaneous Transluminal Coronary Angioplasty). J Am Coll Cardiol, 1988, 12:529-545.
  • 5Surh Y J, Na HK, Lee SS. Transcription factors and mitogenactivated protein kinases as molecular targets for chemoprevention with anti-inflammatory phytochemicals. Biofactors, 2004,21 : 103- 108.
  • 6Dagnell C, Kemi C, Klominek J, et al. Effects of neurotrophins on human bronchial smooth muscle cell migration and matrix metalloproteinase-9 secretion. Transl Res, 2007,150:303-310.
  • 7Luttun A, Lutgens E, Manderveld A, et al. Loss of Matrix metalloproteinase-9 or Matrix metalloproteinase-12 protects apolipoprotein E-deficient mice against atherosclerotic aedia destruction but differentially affects plaque growth, Circulation, 2004,109 : 1408-1414.
  • 8Zeng B, Prasan A, Fung KC, et al. Elevated circulating levels of matrix metalloproteinase-9 and -2 in patients with symptomatic coronary artery disease. Intern Med J, 2005,35:331-335.
  • 9Verna L, Ganda C, Stemerman MB. In vivo low-density lipoprotein exposure induces intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 correlated with activator protein-1 expression. Arterioscler Thromb Vasc Biol, 2006,26 : 1344-1349.
  • 10Chandrasekar B, Mummidi S, Mahimainathan L, et al. Interleukin-18-induced human coronary artery smooth muscle cell migration is dependent on NF-kappaB- and AP-1-mediated matrix metalloproteinase-9 expression and is inhibited by atorvastatin. J Biol Chem. 2006,281:15099-15109.

共引文献24

同被引文献99

  • 1美国糖尿病学会2007版糖尿病诊疗标准[J].中国糖尿病杂志,2007,15(2):129-130. 被引量：112
  • 2Bloom BR,Bennett B.Mechanism of a reaction in vitro associated with delayed-type hypersensitivity[J].Science,1966,153(3731):80-82.
  • 3Gong Z,Xing S,Zheng F,et al.Increased expression of macrophage migration inhibitory factor in aorta of patients with coronary atherosclerosis[J].J Cardiovasc Surg(Torino),2015,56(4):631-637.
  • 4Ogata A,Nishihira J,Suzuki T,et al.Identification of macrophage migration inhibitory factor mRNA expression in neural cells of the rat brain by in situ hybridization[J].Neurosci Lett,1998,246(3):173-177.
  • 5Vedder H,Krieg JC,Gerlach B,et al.Expression and glucocorticoid regulation of macrophage migration inhibitory factor(MIF)in hippocampal and neocortical rat brain cells in culture[J].Brain Res,2000,869(1/2):25-30.
  • 6Zhang W,Li L,Wang J,et al.Expression of macrophage migration inhibitory factor in the mouse neocortex and posterior piriform cortices during postnatal development[J].Cell Mol Neurobiol,2014,34(8):1183-1197.
  • 7Grieb G,Merk M,Bernhagen J,et al.Macrophage migration inhibitory factor(MIF):a promising biomarker[J].Drug News Perspect,2010,23(4):257-264.
  • 8Stojanovic I,Saksida T,Timotijevic G,et al.Macrophage migration inhibitory factor(MIF)enhances palmitic acid-and glucoseinduced murine beta cell dysfunction and destruction in vitro[J].Growth Factors,2012,30(6):385-393.
  • 9Simons D,Grieb G,Hristov M,et al.Hypoxia-induced endothelial secretion of macrophage migration inhibitory factor and role in endothelial progenitor cell recruitment[J].J Cell Mol Med,2011,15(3):668-678.
  • 10Rosado Jde D,Rodriguez-Sosa M.Macrophage migration inhibitory factor(MIF):a key player in protozoan infections[J].Int J Biol Sci,2011,7(9):1239-1256.

二级引证文献36

心血管病学进展
2014年 第1期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部